PSV Trademark

Trademark Overview

On Friday, November 22, 2019, a trademark application was filed for PSV with the United States Patent and Trademark Office. The USPTO has given the PSV trademark a serial number of 88702838. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 26, 2023. This trademark is owned by Agenus Inc.. The PSV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and biopharmaceutical agents, namely, vaccines, immunotherapeutics, and other therapeutic agents, for the prevention and treatment of human diseases, namely, cancers, autoimmune disorders, infectious disease, transplant rejection, and inflammatory disease
psv

General Information

Serial Number88702838
Word MarkPSV
Filing DateFriday, November 22, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 26, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 31, 2020

Trademark Statements

Goods and ServicesPharmaceutical and biopharmaceutical agents, namely, vaccines, immunotherapeutics, and other therapeutic agents, for the prevention and treatment of human diseases, namely, cancers, autoimmune disorders, infectious disease, transplant rejection, and inflammatory disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, November 30, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAgenus Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NameAgenus Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Trademark Events

Event DateEvent Description
Monday, June 26, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 26, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 6, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 5, 2022SOU EXTENSION 5 GRANTED
Tuesday, November 22, 2022SOU EXTENSION 5 FILED
Friday, December 2, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 22, 2022TEAS EXTENSION RECEIVED
Saturday, May 7, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 5, 2022SOU EXTENSION 4 GRANTED
Thursday, May 5, 2022SOU EXTENSION 4 FILED
Thursday, May 5, 2022TEAS EXTENSION RECEIVED
Saturday, November 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 18, 2021SOU EXTENSION 3 GRANTED
Thursday, November 18, 2021SOU EXTENSION 3 FILED
Thursday, November 18, 2021TEAS EXTENSION RECEIVED
Wednesday, May 26, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 24, 2021SOU EXTENSION 2 GRANTED
Monday, May 24, 2021SOU EXTENSION 2 FILED
Monday, May 24, 2021TEAS EXTENSION RECEIVED
Thursday, November 26, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 24, 2020SOU EXTENSION 1 GRANTED
Tuesday, November 24, 2020SOU EXTENSION 1 FILED
Tuesday, November 24, 2020TEAS EXTENSION RECEIVED
Tuesday, May 26, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 31, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 31, 2020PUBLISHED FOR OPPOSITION
Wednesday, March 11, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, February 21, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 20, 2020ASSIGNED TO EXAMINER
Saturday, November 30, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 26, 2019NEW APPLICATION ENTERED

Related Keywords

disease agents namely cancers disorders autoimmune infectious transplant inflammatory rejection